Abstract
This study aimed to evaluate the effectiveness of nursing interventions based on the enhanced recovery after surgery (ERAS) concept in the perioperative management of patients with gynecological malignancies. A retrospective analysis was performed on 101 patients who underwent surgery for gynecological malignancies at our hospital from January 2023 to June 2024. Propensity score matching was used to balance baseline characteristics, resulting in 41 patients in the ERAS intervention group and 41 patients in the conventional care group. Logistic regression analysis was applied to significant variables to control for confounders. After propensity score matching, the ERAS group (59.3 ± 9.1 years) and the conventional care group (60.5 ± 8.6 years) had no significant differences in baseline age (P = .45). The ERAS group demonstrated significantly better outcomes compared to the conventional care group. The ERAS group had a higher proportion of patients who resumed oral intake (95.1% vs 65.0%, P < .01) and ambulated within 24 hours (92.7% vs 58.3%, P < .001). The length of hospital stay was shorter in the ERAS group (5.3 ± 1.2 days vs 6.8 ± 1.5 days, P < .001), and the overall complication rate was lower (12.2% vs 28.3%, P < .05). Pulmonary infection and deep vein thrombosis occurred less frequently in the ERAS group (4.9% vs 12.5%, P < .05 and 2.4% vs 8.3%, P < .05, respectively). On postoperative day 7, psychological health scores were significantly better in the ERAS group (10.2 ± 3.1 vs 14.5 ± 4.2, P < .001). ERAS-based nursing interventions significantly improve postoperative recovery, reduce complications, shorten hospital stays, and enhance psychological well-being in patients with gynecological malignancies. Further research is needed to validate long-term outcomes.